Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 37001-37050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06549582
Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients
NANot yet recruiting
160 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2026
5 conditions1 sponsor0 locations
NCT06456203
Trial of Artificial Intelligence for Chest Radiography
NANot yet recruiting
10,000 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor0 locations
NCT06502106
Internet-delivered Trauma-focused Cognitive-behavioral Therapy as an Early Intervention After Sexual Trauma
NANot yet recruiting
30 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT06227065
Precise Neoadjuvant Chemoresection of Low Grade NMIBC
PHASE2Not yet recruiting
28 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2029
3 conditions2 sponsors1 location
NCT06576037
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
PHASE1Recruiting
128 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2029
1 condition1 sponsor1 location
NCT06545149
SUPPLEMENTATION WITH BETA GLUCAN AND ADAPTATIVE RESPONSE.
NANot yet recruiting
44 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT06434207
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
N/ARecruiting
10 participants
Started: Oct 31, 2024 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT06131502
Sonication-based OCD Neurosurgical Intervention Via Capsulotomy
PHASE1/PHASE2Not yet recruiting
66 participants
Started: Oct 31, 2024 · Completed: Jun 30, 2032
1 condition2 sponsors2 locations
NCT06626555
Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection
PHASE2Not yet recruiting
36 participants
Started: Oct 31, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors0 locations
NCT06694857
A Prospective Evaluation of the Filler for Jaw Contouring
PHASE4Active, not recruiting
15 participants
Started: Oct 31, 2024 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06434194
Serrantor OCT Study
NARecruiting
60 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor2 locations
NCT06561659
Testing a Brief Exercise Intervention in Hoarding Disorder
NANot yet recruiting
22 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06626646
Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)
N/ARecruiting
40 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2025
4 conditions1 sponsor2 locations
NCT06628063
Examination of Pregnant Women in Third Trimester by Ultrasound to Detect Any Congenital Anomalies
N/ANot yet recruiting
40 participants
Started: Oct 31, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor0 locations
NCT06767254
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
N/ARecruiting
200 participants
Started: Oct 30, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor4 locations
NCT06503315
Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.
N/ANot yet recruiting
70 participants
Started: Oct 30, 2024 · Completed: Feb 24, 2026
1 condition1 sponsor1 location
NCT06595342
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
N/ANot yet recruiting
60,000 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2030
2 conditions1 sponsor1 location
NCT05283382
Cannabidiol Effects on Learning and Anxiety
EARLY_PHASE1Recruiting
160 participants
Started: Oct 30, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06679387
"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
PHASE2Recruiting
80 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06678685
Spironolactone Improved Children With NCOR Mutations
PHASE2/PHASE3Not yet recruiting
3 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2025
3 conditions1 sponsor0 locations
NCT06621316
A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
PHASE1/PHASE2Active, not recruiting
74 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06558175
Reirradiation Dose Escalation in Thoracic Cancers
PHASE1Not yet recruiting
48 participants
Started: Oct 30, 2024 · Completed: Jan 29, 2027
3 conditions1 sponsor0 locations
NCT06555744
A Study of ZW191 in Participants With Solid Tumors
PHASE1Recruiting
145 participants
Started: Oct 30, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor18 locations
NCT06020937
Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study
N/ANot yet recruiting
200 participants
Started: Oct 30, 2024 · Completed: Dec 30, 2026
1 condition4 sponsors1 location
NCT06686108
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
PHASE2Recruiting
59 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2028
3 conditions1 sponsor1 location
NCT06656403
Effect of Artificial Tears on Ocular Biometry Parameters
NANot yet recruiting
100 participants
Started: Oct 30, 2024 · Completed: Nov 21, 2024
2 conditions1 sponsor0 locations
NCT06642844
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
PHASE3Not yet recruiting
244 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2029
1 condition24 sponsors0 locations
NCT06591468
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
PHASE2/PHASE3Enrolling by invitation
244 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06691152
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
PHASE1Recruiting
18 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06616038
Heart Failure Biomarkers
N/ANot yet recruiting
114 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2025
2 conditions1 sponsor2 locations
NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
PHASE3Recruiting
975 participants
Started: Oct 30, 2024 · Completed: May 21, 2032
2 conditions1 sponsor110 locations
NCT06972199
Reflexology Massage and Hot Water Foot Bath for Pain and GI Recovery After Colorectal Surgery
NARecruiting
102 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2026
4 conditions1 sponsor2 locations
NCT06656234
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
N/ANot yet recruiting
200 participants
Started: Oct 30, 2024 · Completed: Sep 15, 2028
1 condition1 sponsor1 location
NCT06682572
A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients
PHASE2Recruiting
15 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
2 conditions2 sponsors5 locations
NCT06637813
Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine
N/ANot yet recruiting
1,220 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2034
1 condition1 sponsor0 locations
NCT06570278
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NARecruiting
1,020 participants
Started: Oct 30, 2024 · Completed: Nov 30, 2034
1 condition10 sponsors26 locations
NCT06656949
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NARecruiting
42 participants
Started: Oct 30, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT05993845
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
N/ARecruiting
60 participants
Started: Oct 30, 2024 · Completed: Dec 30, 2025
1 condition3 sponsors3 locations
NCT06648213
Individual Structured Therapy in Early Premature Infants at the Neonatal Intensive Care Unit
NAActive, not recruiting
20 participants
Started: Oct 30, 2024 · Completed: Jul 2, 2025
3 conditions1 sponsor1 location
NCT06633783
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
PHASE3Not yet recruiting
370 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2026
1 condition1 sponsor14 locations
NCT06601335
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE3Recruiting
510 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT06433219
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
PHASE2Active, not recruiting
63 participants
Started: Oct 30, 2024 · Completed: Jan 25, 2028
1 condition2 sponsors84 locations
NCT06361680
Effect of Coenzyme Q10 on Diabetic Children
EARLY_PHASE1Not yet recruiting
100 participants
Started: Oct 30, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT06689852
CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS
NARecruiting
88 participants
Started: Oct 30, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06464380
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
PHASE4Not yet recruiting
40 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
1 condition6 sponsors2 locations
NCT07169214
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
PHASE1Recruiting
36 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06453512
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
NARecruiting
65 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
1 condition3 sponsors1 location
NCT06621095
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
PHASE2Not yet recruiting
104 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06045858
Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)
PHASE3Not yet recruiting
178 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2027
2 conditions1 sponsor0 locations
NCT06561321
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
PHASE2Recruiting
6 participants
Started: Oct 30, 2024 · Completed: Nov 1, 2026
1 condition2 sponsors1 location